Thomas Flaten
Stock Analyst at Lake Street
(0.94)
# 3,698
Out of 4,858 analysts
31
Total ratings
34.38%
Success rate
-10.21%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCX OncoCyte | Maintains: Buy | $5 → $8 | $2.80 | +185.71% | 6 | May 21, 2025 | |
| BDSX Biodesix | Maintains: Buy | $3 → $2 | $0.33 | +506.06% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $18.04 | +94.01% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $3.58 | +123.46% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $3.02 | +98.68% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $5.53 | +62.75% | 2 | Jan 8, 2025 | |
| DERM Journey Medical | Initiates: Buy | $9 | $7.30 | +23.29% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.66 | +353.93% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $3.69 | +198.10% | 3 | Mar 5, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $23.85 | +4.82% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.04 | +70,661.67% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $4.14 | +93.24% | 1 | Jul 7, 2022 |
OncoCyte
May 21, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $2.80
Upside: +185.71%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.33
Upside: +506.06%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $18.04
Upside: +94.01%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.58
Upside: +123.46%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $3.02
Upside: +98.68%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.53
Upside: +62.75%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $7.30
Upside: +23.29%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.66
Upside: +353.93%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $3.69
Upside: +198.10%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $23.85
Upside: +4.82%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.04
Upside: +70,661.67%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $4.14
Upside: +93.24%